MedPAC examines Medicare quality measurement, drug spending
At meetings this week, the Medicare Payment Advisory Commission discussed a wide range of quality-related topics, including measures for long-stay nursing facility residents, behavioral health care and the Medicare program, and reforming quality measurement implications for premium support. Commissioners also examined six proposals MedPAC staff believe have the potential to slow the rate of growth of pharmaceutical spending by Medicare. These options seek to increase price competition, address Part B drug price growth and improve the current payment formula and data. Commissioners also received a status report on Medicare Accountable Care Organizations. The commission will meet again in November.
Related News Articles
Headline
UnitedHealth Group announced Jan. 14 that it launched a six-month pilot program to reduce Medicare Advantage payment processing times by half for rural…
Headline
U.S. health care spending reached $5.3 trillion in 2024 — growing 7.2% from 2023 — the Centers for Medicare & Medicaid Services reported Jan. 14 in Health…
Headline
The AHA Jan. 14 expressed support for the Rural Hospital Cybersecurity Enhancement Act (S. 2169), legislation that would direct the Department of Health and…
Headline
Jesse Tamplen, vice president of care coordination at John Muir Health in San Francisco, and Jamie Elmasu, director of community health improvement at John…
Headline
The AHA, in partnership with the Medical University of South Carolina’s National Mass Violence Center, Jan. 13 released a new guide for hospital and…
Headline
The five-year survival rate for all cancers in the U.S. has reached 70% for the first time, according to a report published Jan. 13 by the American Cancer…